📰 Study Device News
Study Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Device. Real-time updates on events, politics, business and more.
March 26, 2024
26.03.2024 - TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase Technologies Inc. (Theralase or the Company) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic ... Seite 1
March 26, 2024
Theralase(R) to Host Advisory Board Meetings at Canadian Urological ...
May 31, 2023
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
May 31, 2023
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
May 10, 2023
Theralase Provides Update on Phase II Bladder Cancer Study
April 27, 2021
Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter ® Technologies Inc. (" TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (" PDC") and associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses has released the Companys Quarterly Newsletter (" Newsletter") which provides updates on the previous quarter and progress on the Phase II Non...